GGrantIndex
← Search

PHASE III, RANDOMIZED, DOUBLE-BLIND COMPARISON OF THREE PROTEASE INHIBITOR-SP

$78,342M01FY2005RRNIH

University Of California Los Angeles, Los Angeles CA

Investigators

Linked publications & trials

View original record on NIH RePORTER →